ATNM
Actinium Pharmaceuticals, Inc.
Biotechnology
Market Cap$38M
5Y Perf.+5.2%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
ATNM vs RAIN
Revenue, margins, valuation, and 5-year total return — side by side.
RAIN
Rain Enhancement Technologies Holdco Inc
Renewable Utilities
Market Cap$3M
5Y Perf.-61.0%
ATNM vs RAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ATNM | RAIN |
|---|---|---|
| Industry | Biotechnology | Renewable Utilities |
| Market Cap | $38M | $3M |
| Revenue (TTM) | $90K | $0.00 |
| Net Income (TTM) | $-35M | $-6M |
| Gross Margin | -8.1% | — |
| Operating Margin | -414.9% | — |
| Total Debt | $2M | $4M |
| Cash & Equiv. | $73M | $33K |
ATNM vs RAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
ATNM
RAIN
| Stock | Jan 25 | May 26 | Return |
|---|---|---|---|
| Actinium Pharmaceut… (ATNM) | 100 | 105.2 | +5.2% |
| Rain Enhancement Te… (RAIN) | 100 | 39.0 | -61.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ATNM vs RAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ATNM leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and recent price momentum and sentiment. Rain Enhancement Technologies Holdco Inc is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ATNM
Actinium Pharmaceuticals, Inc.
The Growth Play
ATNM carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth -100.0%, EPS growth 30.6%
- -100.0% revenue growth vs RAIN's -121.2%
- -12.9% vs RAIN's -75.1%
Best for: growth exposure
RAIN
Rain Enhancement Technologies Holdco Inc
The Income Pick
RAIN is the clearest fit if your priority is income & stability and long-term compounding.
- beta 1.20
- -80.0% 10Y total return vs ATNM's -97.7%
- Lower volatility, beta 1.20, current ratio 0.12x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ATNM | -100.0% revenue growth vs RAIN's -121.2% |
| Quality / Margins | RAIN | -2.4% margin vs ATNM's -384.4% |
| Stability / Safety | RAIN | Beta 1.20 vs ATNM's 1.40 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | ATNM | -12.9% vs RAIN's -75.1% |
| Efficiency (ROA) | ATNM | -52.3% ROA vs RAIN's -298.9% |
ATNM vs RAIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2023
Segment breakdown not available.
ATNM vs RAIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLATNMLAGGINGRAIN
RAINRain Enhancement Tech…
1leads
ATNMActinium Pharmaceutic…
2leads
6 Total Categories
CATEGORYLEADERvs RAINMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
—
—
Valuation MetricsMultiples, price ratios, and targets
ATNM1/1
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ATNM3/3
Total Returns1Y, 3Y, 5Y total returns with dividends
RAIN4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
ATNM and RAIN operate at a comparable scale, with $90,000 and $0 in trailing revenue.
| Metric | ATNMActinium Pharmace… | RAINRain Enhancement … |
|---|---|---|
| RevenueTrailing 12 months | $90,000 | $0 |
| EBITDAEarnings before interest/tax | -$37M | -$5M |
| Net IncomeAfter-tax profit | -$35M | -$6M |
| Free Cash FlowCash after capex | -$25M | -$4M |
| Gross MarginGross profit ÷ Revenue | -8.1% | — |
| Operating MarginEBIT ÷ Revenue | -414.9% | — |
| Net MarginNet income ÷ Revenue | -384.4% | — |
| FCF MarginFCF ÷ Revenue | -278.2% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +56.8% | — |
Insufficient data to determine a leader in this category.
Valuation Metrics
ATNM leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ATNMActinium Pharmace… | RAINRain Enhancement … |
|---|---|---|
| Market CapShares × price | $38M | $3M |
| Enterprise ValueMkt cap + debt − cash | -$33M | $6M |
| Trailing P/EPrice ÷ TTM EPS | -0.96x | -0.64x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | — |
| Price / BookPrice ÷ Book value/share | 1.12x | — |
| Price / FCFMarket cap ÷ FCF | — | — |
ATNM leads this category, winning 1 of 1 comparable metric.
Profitability & Efficiency
ATNM leads this category, winning 3 of 3 comparable metrics.
Profitability & Efficiency
| Metric | ATNMActinium Pharmace… | RAINRain Enhancement … |
|---|---|---|
| ROE (TTM)Return on equity | -151.7% | — |
| ROA (TTM)Return on assets | -52.3% | -3.0% |
| ROICReturn on invested capital | — | — |
| ROCEReturn on capital employed | -59.5% | — |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 |
| Debt / EquityFinancial leverage | 0.05x | — |
| Net DebtTotal debt minus cash | -$71M | $3M |
| Cash & Equiv.Liquid assets | $73M | $32,604 |
| Total DebtShort + long-term debt | $2M | $4M |
| Interest CoverageEBIT ÷ Interest expense | — | -148.90x |
ATNM leads this category, winning 3 of 3 comparable metrics.
Total Returns (Dividends Reinvested)
RAIN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RAIN five years ago would be worth $2,000 today (with dividends reinvested), compared to $1,674 for ATNM. Over the past 12 months, ATNM leads with a -12.9% total return vs RAIN's -75.1%. The 3-year compound annual growth rate (CAGR) favors RAIN at -41.5% vs ATNM's -47.9% — a key indicator of consistent wealth creation.
| Metric | ATNMActinium Pharmace… | RAINRain Enhancement … |
|---|---|---|
| YTD ReturnYear-to-date | -10.9% | -70.8% |
| 1-Year ReturnPast 12 months | -12.9% | -75.1% |
| 3-Year ReturnCumulative with dividends | -85.9% | -80.0% |
| 5-Year ReturnCumulative with dividends | -83.3% | -80.0% |
| 10-Year ReturnCumulative with dividends | -97.7% | -80.0% |
| CAGR (3Y)Annualised 3-year return | -47.9% | -41.5% |
RAIN leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
Evenly matched — ATNM and RAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
RAIN is the less volatile stock with a 1.20 beta — it tends to amplify market swings less than ATNM's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ATNM currently trades 62.6% from its 52-week high vs RAIN's 15.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ATNMActinium Pharmace… | RAINRain Enhancement … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 1.20x |
| 52-Week HighHighest price in past year | $1.95 | $9.58 |
| 52-Week LowLowest price in past year | $0.95 | $1.43 |
| % of 52W HighCurrent price vs 52-week peak | +62.6% | +15.2% |
| RSI (14)Momentum oscillator 0–100 | 52.8 | 33.7 |
| Avg Volume (50D)Average daily shares traded | 184K | 19K |
Evenly matched — ATNM and RAIN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ATNMActinium Pharmace… | RAINRain Enhancement … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
ATNM leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). RAIN leads in 1 (Total Returns). 1 tied.
Best OverallActinium Pharmaceuticals, I… (ATNM)Leads 2 of 6 categories
Loading custom metrics...
ATNM vs RAIN: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — ATNM or RAIN?
Over the past 5 years, Rain Enhancement Technologies Holdco Inc (RAIN) delivered a total return of -80.
0%, compared to -83. 3% for Actinium Pharmaceuticals, Inc. (ATNM). Over 10 years, the gap is even starker: RAIN returned -80. 0% versus ATNM's -97. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — ATNM or RAIN?
By beta (market sensitivity over 5 years), Rain Enhancement Technologies Holdco Inc (RAIN) is the lower-risk stock at 1.
20β versus Actinium Pharmaceuticals, Inc. 's 1. 40β — meaning ATNM is approximately 17% more volatile than RAIN relative to the S&P 500.
03Which is growing faster — ATNM or RAIN?
On earnings-per-share growth, the picture is similar: Actinium Pharmaceuticals, Inc.
grew EPS 30. 6% year-over-year, compared to -34. 9% for Rain Enhancement Technologies Holdco Inc. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — ATNM or RAIN?
Rain Enhancement Technologies Holdco Inc (RAIN) is the more profitable company, earning 0.
0% net margin versus -384. 4% for Actinium Pharmaceuticals, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RAIN leads at 0. 0% versus -414. 9% for ATNM. At the gross margin level — before operating expenses — RAIN leads at 0. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — ATNM or RAIN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is ATNM or RAIN better for a retirement portfolio?
For long-horizon retirement investors, Rain Enhancement Technologies Holdco Inc (RAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
20)). Both have compounded well over 10 years (RAIN: -80. 0%, ATNM: -97. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between ATNM and RAIN?
These companies operate in different sectors (ATNM (Healthcare) and RAIN (Utilities)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.